https://www.selleckchem.com/pr....oducts/tinengotinib.
0; 95% CI 1.7-5.2), neurologic complications (OR, 4.7; 95% CI 1.5-15.2), and pulmonary hemorrhage (OR 6.4; 95% CI 1.3-33.2) were associated with increased mortality, whereas Fontan physiology was no longer associated, suggesting the association of Fontan physiology with mortality may be mediated by complications. Fontan physiology was also a risk factor for neurologic complications (OR 8.2; 95% CI 3.3-20.9). Given the rapid increase in ECLS use, understanding risk factors for ACHD patients receiving ECLS after cardiac surgery will
Like
Comment
Share
